Mumps antibody levels among students before a mumps outbreak: In search of a correlate of immunity

Journal of Infectious Diseases

Volumn 204, Issue 9, 2011, Pages 1413-1422

  Cortese, Margaret M ^a   Barskey, Albert E ^a   Tegtmeier, Gary E ^c   Zhang, Cheryl ^d   Ngo, Laurie ^d   Kyaw, Moe H ^a   Baughman, Andrew L ^b   Menitove, Jay E ^c   Hickman, Carole J ^a   Bellini, William J ^a   Dayan, Gustavo H ^a   Hansen, Gail R ^e   Rubin, Steven ^d  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Division of New York Blood Center Enterprises   (United States)

^d CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^e KANSAS DEPARTMENT OF HEALTH AND ENVIRONMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

JERYL LYNN VIRUS ANTIBODY; MUMPS ANTIBODY; MUMPS VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; EPIDEMIC; FEMALE; HUMAN; JERYL LYNN VIRUS; MALE; MUMPS; MUMPS VIRUS; PRIORITY JOURNAL; SYMPTOM; UNITED STATES; VIRUS NEUTRALIZATION; VIRUS STRAIN;

ADOLESCENT; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BIOLOGICAL MARKERS; DISEASE OUTBREAKS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IOWA; MALE; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS; STUDENTS; VIRAL PLAQUE ASSAY; YOUNG ADULT;

EID: 80053429315     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir526     Document Type: Article

References (20)

1. Dayan GH, Quinlisk MP, Parker AA, et al. Recent resurgence of mumps in the United States. N Engl J Med 2008; 358:1580-9. (Pubitemid 351519818)
2. Barskey AE, Glasser JW, LeBaron CW. Mumps resurgences in the United States: a historical perspective on unexpected elements. Vaccine 2009; 27:6186-95.
3. Watson JC, Hadler SC, Dykewicz CA, Reef S, Phillips L. Measles, mumps, and rubella-vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1998; 47:1-57.
4. Cortese MM, Jordan HT, Curns AT, et al. Mumps vaccine performance among university students during a mumps outbreak. Clin Infect Dis 2008; 46:1172-80. (Pubitemid 351589899)
5. Huang AS, Cortese MM, Curns AT, et al. Risk factors for mumps at a university with a large mumps outbreak. Public Health Rep 2009; 124:419-26.
6. Rubin SA, Qi L, Audet SA, et al. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak. J Infect Dis 2008; 198:508-15.
7. Orvell C, Tecle T, Johansson B, Saito H, Samuelson A. Antigenic relationships between six genotypes of the small hydrophobic protein gene of mumps virus. J Gen Virol 2002; 83:2489-96.
8. Yates PJ, Afzal MA, Minor PD. Antigenic and genetic variation of the HN protein of mumps virus strains. J Gen Virol 1996; 77:2491-7. (Pubitemid 26348371)
9. Pipkin PA, Afzal MA, Heath AB, Minor PD. Assay of humoral immunity to mumps virus. J Virol Method 1999; 79:219-25. (Pubitemid 29221995)
10. Cohen BJ, Audet S, Andrews N, Beeler J. WHO working group on measles plaque reduction neutralization test. Vaccine 2007; 26:59-66.
11. Bitsko RH, Cortese MM, Dayan GH, et al. Detection of RNA of mumps virus during an outbreak in a population with a high level of measles, mumps, and rubella vaccine coverage. J Clin Microbiol 2008; 46:1101-3. (Pubitemid 351380007)
12. Ennis FA. Immunity to mumps in an institutional epidemic. Correlation of insusceptibility to mumps with serum plaque neutralizing and hemagglutination-inhibiting antibodies. J Infect Dis 1969; 119:654-7.
13. Meyer MB, Stifler WC, Joseph JM. Evaluation of mumps vaccine given after exposure to mumps, with special reference to the exposed adult. Pediatrics 1966; 37:304-15.
14. Bashe WJ, Gotlieb T, Henle G, Henle W. Studies on the prevention of mumps. VI. The relationship of neutralizing antibodies to the determination of susceptibility and to the evaluation of immunization procedures. J Immunol 1953; 71:76-85.
15. Brunell PA, Brickman A, O'Hare D, Steinberg S. Ineffectiveness of isolation of patients as a method of preventing the spread of mumps. Failure of the mumps skin-test antigen to predict immune status. N Engl J Med 1968; 279:1357-61.
16. Marin M, Quinlisk P, Shimabukuro T, Sawhney C, Brown C, Lebaron CW. Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college studentsdIowa, 2006. Vaccine 2008; 26:3601-7.
17. Sosin DM, Cochi SL, Gunn RA, Jennings CE, Preblud SR. Changing epidemiology of mumps and its impact on university campuses. Pediatrics 1989; 84:779-84. (Pubitemid 19265147)
18. Henle G, Henle W, Wendell KK, Rosenberg P. Isolation of mumps virus from human beings with induced apparent or inapparent infections. J Exp Med 1948; 88:223-32.
19. Falk WA, Buchan A, Dow M, et al. The epidemiology of mumps in southern Alberta 1980-1982. Am J Epidemiol 1989; 130:736-49. (Pubitemid 19240202)
20. Cooney MK, Fox JP, Hall CE. The Seattle Virus Watch. VI. Observations of infections with and illness due to parainfluenza, mumps and respiratory syncytial viruses and Mycoplasma pneumoniae. Am J Epidemiol 1975; 101:532-51.